SCHEMBL12210645

SCHEMBL12210645

Cc1c(C(=O)N2CCCn3nc(C(=O)NO)cc3C2)oc2ccccc12

nearest known ligand 0.55

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.55
▸ HTT P42858 2/20 0.55
▸ RECQL P46063 2/20 0.55
▸ HPGD P15428 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ HDAC6 Q9UBN7 3/20 0.51
▸ NPC1 O15118 3/20 0.51
▸ KMT2A Q03164 4/20 0.49
▸ MEN1 O00255 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.46
▸ CASP6 P55212 1/20 0.45
▸ RAB9A P51151 2/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ LMNA P02545 1/20 0.43
▸ POLB P06746 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ GLA P06280 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12210580 0.74 HDAC6 (0.88) ALDH1A1TSHRHDAC6KMT2ASMN1; SMN2
SCHEMBL2524455 0.73 HDAC6 (0.57) ALDH1A1HDAC6LMNA
SCHEMBL12210635 0.73 HDAC6 (0.89) HDAC6MAPT
SCHEMBL2522947 0.72 HDAC6 (0.88) ALDH1A1HTTHPGDHDAC6L3MBTL1
SCHEMBL12210627 0.72 HDAC6 (0.61) HDAC6L3MBTL1
SCHEMBL12285743 0.72 HDAC6 (0.52) HDAC6NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL2524714 0.69 HDAC6 (0.53) HDAC6NPC1RAB9AMAPT
SCHEMBL14880019 0.69 SMN1; SMN2 (0.62) HTTTSHRNPC1KMT2AL3MBTL1
SCHEMBL12210588 0.68 HDAC6 (1.00) HDAC6KMT2ASMN1; SMN2
SCHEMBL12210524 0.67 HDAC6 (1.00) HDAC6KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150175614-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2015-06-25 — — US disclosed
US-20150175614-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2015-06-25 — — US disclosed
US-20150175614-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. 2015-06-25 — — US disclosed
US-8946223-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-02-03 — — US disclosed
US-8946223-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-02-03 — — US disclosed
US-8946223-B2 Substituted hydroxamic acids and uses thereof MILLENNIUM PHARMACEUTICALS, INC. (US) 2015-02-03 — — US disclosed
US-20110251184-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-10-13 — — US disclosed
US-20110251184-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2011-10-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150175614-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, H1-3 ALDH1A1 828/4885HTT 76/4885RECQL 1331/4885
US-20110251184-A1 SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, H1-3 ALDH1A1 828/4885HTT 76/4885RECQL 1331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback